Key result
Overnight hospitalization after percutaneous coronary intervention in patients with chronic coronary artery disease is a safe strategy that reduces treatment costs by 21.2% compared to standard hospitalization.
Why the study?
New treatment plans reducing hospital stay to 24 hours with next-morning discharge (overnight stay) are being introduced for patients with chronic coronary artery disease after endovascular interventions.
Does percutaneous coronary intervention with overnight hospitalization reduce costs and maintain safety compared to standard 5-8 day hospitalization in patients with stable coronary artery disease?
Does percutaneous coronary intervention with overnight hospitalization reduce costs and maintain safety compared to standard 5-8 day hospitalization in patients with stable coronary artery disease?
Overnight hospitalization after percutaneous coronary intervention in stable CAD patients is safe and provides significant cost savings compared to standard 5-8 day stays in the Russian healthcare setting.
Answers are grounded in this paper and cite their sources.
Supports overnight discharge after elective PCI for cost savings in stable CAD; leaves open confirmation via randomized trials before practice change.
New methods and treatment plans for patients with chronic coronary artery disease after endovascular interventions are currently introduced into clinical practice. It allows reducing hospital stay down to 24 hour, with discharge the next morning. This approach is called overnight stay. Using a similar strategy increases the availability of various types of endovascular interventions, shorter waiting lists, and cut the cost of treatment due to a reduced hospital stay.
No takes yet. Share an insight, caveat, or question.
Basinkevich et al. (2020) conducted a review in chronic coronary artery disease. Percutaneous coronary intervention with overnight hospitalization vs. Standard hospitalization was evaluated. Overnight hospitalization after percutaneous coronary intervention in patients with chronic coronary artery disease is a safe strategy that reduces treatment costs by 21.2% compared to standard hospitalization.
Synapse has enriched 10 related papers. Consider them for comparative context: